Brief: Alphamab Oncology Says Unit Has Passed On-Site Inspection Of An European Union Qualified Person
07/02/2020 01:24
Feb 7 (Reuters) - Alphamab Oncology 9966.HK :
* UNIT HAS PASSED ON-SITE INSPECTION OF AN EUROPEAN UNION
QUALIFIED PERSON
* INSPECTION IS FOR PREPARATION OF RELIABLE SUPPLY FOR
GLOBAL
CLINICAL TRIALS, SUBSEQUENT COMMERCIALIZATION OF KN035
Source text for Eikon: urn:newsml:reuters.com:*:nHKS16RSbJ
Further company coverage: 9966.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alphamab Oncology
See all newsBrief: Alphamab Oncology Says Fei Wang Resigns As Chief Financial Officer
Brief: Alphamab Oncology Says First Patient Dosed In Phase III Clinical Study Of JSKN033 Monotherapy For Treatment Of Cervical Cancer
Brief: Alphamab Oncology Says Board Resolves To Repurchase Shares Up To HK$80 Million In Value
Brief: Alphamab Oncology Says NMPA Accepts NDA For Anbenitamab With HB1801 For Her2+ Advanced Breast Cancer
Brief: Alphamab Oncology Says NMPA Accepts NDA For Anbenitamab (KN026)